Southville International School and Colleges
Dihydropyrimidine Dehydrogenase Is a Prognostic Marker for Mesenchymal Stem Cell-Mediated Cytosine Deaminase Gene and 5-Fluorocytosine Prodrug Therapy for the Treatment of Recurrent Gliomas - Theranostics 2016 - 6:10

--Medical Technology--Medtech
Powered by Koha